Susanna Fletcher Greer, Chief Scientific Officer of the V Foundation, shared a post on LinkedIn:
“A new V Foundation funded study shows that some patients who respond completely to chemotherapy plus immunotherapy may safely keep their bladder. What makes this possible is not guesswork, but molecular monitoring.
Tumor DNA in blood helped identify who was at risk for hidden metastasis. Tumor DNA in urine detected cancer lingering inside the bladder, even when biopsies looked clean. This is precision oncology at its best.”
Other articles featuring Susanna Fletcher Greer on OncoDaily.